Open Access

Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats

  • Authors:
    • Di Zhang
    • Yan‑Juan Yu
    • Feng‑Sen Xu
    • Jun‑Hua Yuan
    • Rui Wang
    • Cai‑Shun Zhang
    • Liu‑Xin Wang
    • Yuan Liu
    • Li‑Min Song
    • Jun‑Li Liu
    • Jing Dong
  • View Affiliations

  • Published online on: October 1, 2019     https://doi.org/10.3892/mmr.2019.10719
  • Pages: 4523-4532
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Betatrophin [also known as lipasin, angiopoietin‑like 8 (ANGPTL8), refeeding induced in fat and liver (RIFL), or hepatocellular carcinoma‑associated gene TD26], a 22‑kDa protein in the angiopoietin‑like family, is a liver‑derived hormone that promotes pancreatic β‑cell proliferation and lipid metabolism. The aim of the present study was to investigate the effect of recombinant betatrophin on β‑cell regeneration in a neonatal streptozotocin (STZ)‑induced diabetic rat model. One‑day‑old Wistar rats were injected with STZ (100 mg/kg), followed by intraperitoneal administration of betatrophin to the STZ‑injected rats for 6 days. Plasma glucose and body weight were monitored. On days 4 and 7, expression levels of pancreatic duodenal homeobox gene‑1 (PDX‑1), the Bax/B‑cell lymphoma‑2 (Bcl‑2) ratio and plasma insulin were assessed, and the β‑cell proliferation rate was determined. Pancreatic islet area and number were determined at 10 weeks. It was found that betatrophin treatment alleviated STZ‑induced hyperglycemia, elevated pancreatic expression levels of Bcl‑2, PDX‑1, plasma insulin levels and the β‑cell proliferation rate on days 4 and 7. Long‑term betatrophin treatment improved glucose tolerance, associated with improved plasma insulin levels and β‑cell mass. These results suggest that early administration of betatrophin promotes β‑cell proliferation in STZ‑induced diabetic neonates and prevents the development of diabetes in adults.
View Figures
View References

Related Articles

Journal Cover

November-2019
Volume 20 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang D, Yu YJ, Xu FS, Yuan JH, Wang R, Zhang CS, Wang LX, Liu Y, Song LM, Liu JL, Liu JL, et al: Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats. Mol Med Rep 20: 4523-4532, 2019.
APA
Zhang, D., Yu, Y., Xu, F., Yuan, J., Wang, R., Zhang, C. ... Dong, J. (2019). Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats. Molecular Medicine Reports, 20, 4523-4532. https://doi.org/10.3892/mmr.2019.10719
MLA
Zhang, D., Yu, Y., Xu, F., Yuan, J., Wang, R., Zhang, C., Wang, L., Liu, Y., Song, L., Liu, J., Dong, J."Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats". Molecular Medicine Reports 20.5 (2019): 4523-4532.
Chicago
Zhang, D., Yu, Y., Xu, F., Yuan, J., Wang, R., Zhang, C., Wang, L., Liu, Y., Song, L., Liu, J., Dong, J."Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats". Molecular Medicine Reports 20, no. 5 (2019): 4523-4532. https://doi.org/10.3892/mmr.2019.10719